In the MMTV-PyMT transgenic mouse model, which recapitulates the step-wise progression of human breast cancer [12], the loss of mACKR4 led to an increase in intratumor CD8+ T cells and CD103+ DCs and inhibited tumor development [12]. This evidence concerns the gene CD8A and neoplasm.